Literature DB >> 16581575

Squamous cell carcinoma of the eyelid arising from palpebral conjunctiva.

Sei-Ichiro Motegi1, Atsushi Tamura, Yoichiro Matsushima, Yayoi Nagai, Osamu Ishikawa.   

Abstract

We reported a 58-year-old Japanese man with squamous cell carcinoma (SCC) of the left upper eyelid arising from the palpebral conjunctiva. The tumor had been incised by a former doctor under the diagnosis of chalazion. Histopathological examination of the relapsed tumor revealed atypical squamous cells invading towards the eyelid skin from the epithelium of palpebral conjunctiva. We performed a total resection of the tumor and reconstructed the upper eyelid by the technique of Mustarde's switch flap. During 10 months of follow-up, neither local recurrence nor metastasis has been detected and the reconstructed eyelids showed good course in function and in appearance. SCC of the palpebral conjunctiva is quite rare, however, it often resembles chronic conjunctivitis or chalazion. It is important to consider the possibility of SCC in addition to sebaceous carcinoma when we see a patient with an eyelid lesion, even one which looks like a benign condition such as chronic conjunctivitis or chalazion.

Entities:  

Mesh:

Year:  2006        PMID: 16581575

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

1.  Intraepithelial and invasive squamous neoplasms of the conjunctiva in Ibadan, Nigeria: a clinicopathological study of 46 cases.

Authors:  Gabriel O Ogun; Olufunmilola A Ogun; Charles O Bekibele; Effiong E Akang
Journal:  Int Ophthalmol       Date:  2008-09-11       Impact factor: 2.031

2.  Primary squamous cell carcinoma arising from palpebral conjunctiva: A rare presentation.

Authors:  H Vijaya Pai; Divya Handa; J Padma Priya
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

3.  Squamous cell carcinoma of the lacrimal punctum: A rare presentation.

Authors:  Akshay Gopinathan Nair; Indumati Gopinathan; Vandana Jain
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.